Michigan biotech gets Series B funding to expand sustainable polymer production replacing synthetic plastic materials ...
Bio-Rad has been challenged by tough end-market conditions in life sciences tools, but the outlook for 2025 is better. The company's cautious approach has led to lackluster sales growth and margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results